...Thank you, Richa. Greetings to everyone, and a warm welcome to our Q1 FY 2024 earnings call. We had a strong start to the year with robust sales and record profitability. I'll start today with an overview of our financials for the quarter. For this section, all the amounts are translated into U.S. dollar at a convenient translation rate of INR 82.06, which is the rate as of 30th June 2023. Consolidated revenues for the quarter stood at INR 6,738 crores, that is USD 821 million and grew by 29% on year-on-year basis and by 7% on a sequential quarter basis. Adjusted for brand divestment income on a rebase comparator, the underlying growth was higher at 35% on Y-o-Y basis and 12% sequentially. The growth was driven by the generics business mainly in U.S., Emerging Markets and Europe. Excluding the one-off gains from brand divestment, loss of revenue from divested portfolio and NLEM related price reduction, India business registered a high single-digit growth. Consolidated gross profit margin...